RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Study on the incidence of testicular and epididymal appendages in patients with cryptorchidism.

OBJECTIVE: To study the incidence of testicular and epididymal appendages in patients with cryptorchidism.

MATERIALS AND METHODS: We studied 65 patients with cryptorchidism, totalizing 83 testes and 40 patients who had prostate adenocarcinoma and hydrocele (control group), totalizing 55 testes. The following situations were analyzed: I) absence of testicular and epididymal appendages, II) presence of testicular appendage only, III) presence of epididymal appendage, IV) presence of testicular and epididymal appendage, V) presence of 2 epididymal appendages and 1 testicular appendage and VI) presence of paradidymis or vas aberrans of Haller.

RESULTS: In patients with cryptorchidism we found testicular appendages in 23 cases (41.8%), epididymal appendages in 9 (16.3%), testicular and epididymal appendage in 8 (14.5%), 2 epididymal appendages and 1 testicular in 1 (1.8%) and absence of appendages in 14 (25.4%). In the control group, we found testicular appendages in 29 (34.9%), epididymal appendages in 19 (22.8%), testicular and epididymal appendage in 7 (8.4%), and absence of appendages in 28 (33.7%), we did not find 2 epididymal appendages in this group, and none of the patients in the 2 groups presented paradidymis or vas aberrans of Haller.

CONCLUSION: The occurrence of testicular and epididymal appendages is quite variable. There was no statistically significant difference in the incidence and distribution of the testicular and epididymal appendages between patients with cryptorchidism and those from the control group.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app